Disease-A-Month RSS feed: Current Issue. Designed for primary care physicians, each issue of Disease-a-Month presents an in-depth review of a single topic. In this way, the publication can cover all aspects of the topic-pathophysiology, clinical features of the disease or condition, diagnostic techniques, therapeutic approaches, and prognosis. http://www.diseaseamonth.com/?rss=yesElsevier Inc.en © 2012 Published by Elsevier Inc. All rights reserved. Disease-A-Month0011-5029582February 2012 © 2012 Published by Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.diseaseamonth.com/article/PIIS001150291100318X/abstract?rss=yesEditorial Board10.1016/S0011-5029(11)00318-XDisease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-9IFCIFChttp://www.diseaseamonth.com/article/PIIS0011502911003191/abstract?rss=yesTitle Page10.1016/S0011-5029(11)00319-1Disease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-93333http://www.diseaseamonth.com/article/PIIS0011502911003208/abstract?rss=yesInformation for Readers10.1016/S0011-5029(11)00320-8Disease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-93434http://www.diseaseamonth.com/article/PIIS001150291100321X/abstract?rss=yesTable of Contents10.1016/S0011-5029(11)00321-XDisease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-93536http://www.diseaseamonth.com/article/PIIS0011502911002616/abstract?rss=yesMethamphetamine has a typical history of an illicit drug in that it actually was initially developed several decades ago to treat a variety of maladies ranging from weight loss to asthma to Parkinson's disease. As a sympathomimetic amine related to ephedrine and amphetamine with central nervous system stimulant properties, the illegal manufacture and use of methamphetamine exploded (first in the Midwestern USA, due to easy access to anhydrous ammonia) by the mid-1990s. Today, methamphetamine abuse is no longer a regional issue (confined by socioeconomic demographics), but an international problem with increasing potency (and availability) and has become a major concern that every primary care physician (whether urban or rural) must address. Dr. David Vearrier and colleagues from Drexel University College of Medicine give an excellent in-depth overview that is a valuable resource for the primary care practitioner.ForewordJerrold B. Leikin10.1016/j.disamonth.2011.09.005Disease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-93737http://www.diseaseamonth.com/article/PIIS0011502911002604/abstract?rss=yesDeveloped as an amphetamine derivative, methamphetamine quickly became a popular medication during the 1940s and 1950s, prescribed for a variety of indications. Extensive diversion of methamphetamine during the 1960s and an increasing awareness of the adverse health effects associated with methamphetamine led to the withdrawal of most of the indications for licit methamphetamine use and declines in legal production of the drug. However, the illicit manufacture of methamphetamine increased to meet the demand for methamphetamine, and methamphetamine abuse has increased with variable geographic penetrance over the last 30 years.Methamphetamine: History, Pathophysiology, Adverse Health Effects, Current Trends, and Hazards Associated with the Clandestine Manufacture of MethamphetamineDavid Vearrier, Michael I. Greenberg, Susan Ney Miller, Jolene T. Okaneku, David A. Haggerty10.1016/j.disamonth.2011.09.004Disease-A-Month 58, 2 (2012)2012-02-01Disease-A-Month2012-02-01582S0011-5029(11)X0015-93889